Johnson & Johnson’s profit for the first quarter shot up as the coronavirus health crisis drove demand for over-the-counter medicine, though it said it would see a decline in sales this year as it spends more in response to the pandemic.

The New Brunswick, N.J., company posted net income of $5.8 billion, or $2.17 a share, compared with $3.75 billion, or $1.39 a share, in the comparable quarter last year.


Read More